News
$Tonix Pharmaceuticals (TNXP.US)$ Reuters
·
2 mins ago
Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® Symtouch® to Treat Migraines
·
2 mins ago
Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® Symtouch® to Treat Migraines
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
